Main Article Content
Abstract
Methods:The study was conducted at private clinic. All patients having erectile dysfunction (ED) after marriage with normal nocturnal erections were enrolled in this prospective study for two years(2008-2009). They were visiting private clinic either directly or referred from dermatologist colleague in Nassirya city. Reassurance & Sildenafil 100 mg at bed time was given to every patient and dose reduced to 50 mg after 3 successful intercourses. Patients who did not respond to PDE-5 inhibitor (3 doses), were given sex therapy(Master and Johnson technique)and shifted to. Sildenafil after successful intercourse.
Results: Total number of patients was 45 with age range of 20-39 years. Mean duration elapsed before seeking medical advice was 10±14 days. Eighty percent patients had successful intercourse on first dose of Sildenafil with 95% confidence interval (CI) and 13% patients responded to 2nd dose of Sildenafil. Twelve percent patients suffered mild, well tolerable complications.
Conclusions: Wedding night impotence is not an uncommon condition in some special population. Sildenafil proved to be effective, with high success rate and few tolerable complications.
Keywords
Article Details
References
- Sharlip ID. Evaluation and nonsurgical management of erectile dysfunction. Urol Clin North Am. 1998;25:647-59.
- NIH Consensus Conference Impotence. NIH Consensus Development Panel on Impotence.JAMA. 1993;270:83-90.
- Lue TF. Impotence: a patient’s goal-directed approach to treatment. World J Urol. 1990;8:67-74.
- LoPiccolo J. Postmodern sex therapy for erectile failure. In: Rosen RC, Leibtum SR, editors. Erectile disorders: Assessment and treatment. New York: Gullford Press 1992:171-97.
- Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med. 1978;299:111-5.
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168:1332-6.
- Althof SE. Quality of life and erectile dysfunction. Urology. 2002;59:803-10.
- Manning M, Junemann K. Pharmacotherapy of Erectile Dysfunction. In Male infertility and Honeymoon Impotence International Journal of Nephrology & Urology, 2009; 1(2):103-107 Muhammad Akram Malik et al 107 Sexual dysfunction. Hellstorm WJG, editor. New York: Springer-Verlag 1997:440-51.
- Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown 1970.
- Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-404.
- Ghanem H, Sherif T, Adbel-Gawad T, Asaad T. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction. Int J Impot Res. 1998;10:211-4.
- Hirsch M, Donatucci C, Glina S, Montague D, Montorsi F, Wyllie M. Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculation. J Sex Med. 2004;1:87-91.
- Gingell C, Sultana SR, Wulff MB, Gepi-Attee S. Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med. 2004;1:179-84.
- El-Meliegy A. A retrospective study of 418 patients with honeymoon impotence in an
- andrology clinic in Jeddah, Saudi Arabia. Eur J Sexol. 2004;13:1-4.
- Shamloul R. Management of honeymoon impotence. J Sex Med. 2006;3:361-6.
References
Sharlip ID. Evaluation and nonsurgical management of erectile dysfunction. Urol Clin North Am. 1998;25:647-59.
NIH Consensus Conference Impotence. NIH Consensus Development Panel on Impotence.JAMA. 1993;270:83-90.
Lue TF. Impotence: a patient’s goal-directed approach to treatment. World J Urol. 1990;8:67-74.
LoPiccolo J. Postmodern sex therapy for erectile failure. In: Rosen RC, Leibtum SR, editors. Erectile disorders: Assessment and treatment. New York: Gullford Press 1992:171-97.
Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med. 1978;299:111-5.
Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168:1332-6.
Althof SE. Quality of life and erectile dysfunction. Urology. 2002;59:803-10.
Manning M, Junemann K. Pharmacotherapy of Erectile Dysfunction. In Male infertility and Honeymoon Impotence International Journal of Nephrology & Urology, 2009; 1(2):103-107 Muhammad Akram Malik et al 107 Sexual dysfunction. Hellstorm WJG, editor. New York: Springer-Verlag 1997:440-51.
Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown 1970.
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-404.
Ghanem H, Sherif T, Adbel-Gawad T, Asaad T. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction. Int J Impot Res. 1998;10:211-4.
Hirsch M, Donatucci C, Glina S, Montague D, Montorsi F, Wyllie M. Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculation. J Sex Med. 2004;1:87-91.
Gingell C, Sultana SR, Wulff MB, Gepi-Attee S. Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med. 2004;1:179-84.
El-Meliegy A. A retrospective study of 418 patients with honeymoon impotence in an
andrology clinic in Jeddah, Saudi Arabia. Eur J Sexol. 2004;13:1-4.
Shamloul R. Management of honeymoon impotence. J Sex Med. 2006;3:361-6.